Medicare price negotiation list: What it means for pharma companies

Yahoo Finance Video
176,694 次觀看・8 個月前

On Tuesday, the Biden administration listed ten drugs subject to Medicare price negotiations. Yahoo Finance Health Care Reporter Anjalee Khemlani breaks down the list and how this may impact the pharmaceutical companies who profit from these drugs.  

The ten drugs and pharma companies impacted are: 

Eliquis - Bristol-Myers Squibb (BMY), Pfizer (PFE)

Jardiance - Boehringer Ingelheim, Eli Lilly (LLY)

Xarelto- Bayer (BAYRY), Johnson & Johnson (JNJ)

Januvia - Merck (MRK)

Farxiga - AstraZeneca (AZN)

Entresto - Novartis (NVS)

Enbrel - Amgen (AMGN)

Imbruvica - Johnson & Johnson (JNJ), AbbVie (ABBV)

Stelara - Johnson & Johnson (JNJ)

Fiasp, NovoLog - Novo Nordisk (NVO)